BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs2230926
,
ZBTB7A
,
Metabolism of xenobiotics
,
Obesity
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tyrosine kinase receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic kidney HEK293T cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
NTRK fusions and Trk proteins: what are they and how to test for them.
Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expre…
NTRK point mutations and their functional consequences.
NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic dete…
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotac…
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-…
A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Me…
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ